Manel Bosch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manel Bosch has a total of 197 co-authors. Here are the top co-authors by number of shared publications:
- Vicente Marchán
Departament de Química Inorgànica i Orgànica, Secció de Química Orgànica, Universitat de Barcelona (UB) and Institut de Biomedicina de la Universitat de Barcelona (IBUB) Barcelona Spain
17 shared publications - Eduardo Izquierdo-García
Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences Laboratory For Inorganic Chemical Biology Paris France
7 shared publications Albert Gandioso
Departament de Química Inorgànica i Orgànica, Secció de Química Orgànica, Universitat de Barcelona (UB), Institut de Biomedicina de la Universitat de Barcelona (IBUB), Martí i Franquès 1-11, E-08028 Barcelona, Spain
5 shared publicationsAnna Rovira
Departament de Química Inorgànica i Orgànica, Secció de Química Orgànica, Universitat de Barcelona (UB), and Institut de Biomedicina de la Universitat de Barcelona (IBUB), Martí i Franquès 1-11, E-08028 Barcelona, Spain
5 shared publications- José Ruiz
Departamento de Química Inorgánica, Universidad de Murcia, and Murcia BioHealth Research Institute (IMIB-Arrixaca), E-30100 Murcia, Spain
5 shared publications - Santi Nonell
Institut Químic de Sarrià Universitat Ramon Llull Barcelona Spain
5 shared publications
Latest Publications
- Open Access
- 23 June 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (34)
π‐Extended COUPY Fluorophores for Targeted Near‐Infrared Fluorescence and Lifetime Imaging in Live Cells
Fluorescent probes operating in the near‐infrared (NIR) region offer deep‐tissue visualization with minimal background interference, reduced phototoxicity, and enhanced signal‐to‐noise ratios. However, most conventional NIR fluorophores exhibit poor photostability, low fluorescence quantum yields, and limited chemical versatility, which constrain their use in demanding biological environments. Here, we report a new family of π‐extended COUPY dyes ( 3 – 7 ), rationally engineered to deliver efficient far‐red/NIR performance through vinylogation of the exocyclic double bond of the coumarin scaffold. This single structural modification induces a bathochromic shift exceeding 100 nm in both absorption and emission spectra while preserving the compact architecture and synthetic accessibility of the parent coumarin. The resulting dyes combine high molar absorptivity, moderate‐to‐high quantum yields, and exceptional photostability under biologically‐relevant conditions. Their performance was validated in live‐cell imaging using both intensity‐based and fluorescence lifetime imaging microscopy (FLIM), demonstrating compatibility with advanced imaging techniques. Furthermore, site‐specific bioconjugation to a clinically relevant peptide confirmed their suitability for targeted imaging. Collectively, π‐extended COUPY dyes represent a promising class of synthetically modular, chemically robust, and biologically compatible far‐red/NIR fluorophores for high‐resolution imaging, targeted strategies, and advanced bioimaging modalities, and provide a foundation for future studies aimed at evaluating their performance in more complex biological models.
- 23 June 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (34)
Open Accessπ‐Extended COUPY Fluorophores for Targeted Near‐Infrared Fluorescence and Lifetime Imaging in Live Cells
Fluorescent probes operating in the near‐infrared (NIR) region offer deep‐tissue visualization with minimal background interference, reduced phototoxicity, and enhanced signal‐to‐noise ratios. However, most conventional NIR fluorophores exhibit poor photostability, low fluorescence quantum yields, and limited chemical versatility, which constrain their use in demanding biological environments. Here, we report a new family of π‐extended COUPY dyes ( 3 – 7 ), rationally engineered to deliver efficient far‐red/NIR performance through vinylogation of the exocyclic double bond of the coumarin scaffold. This single structural modification induces a bathochromic shift exceeding 100 nm in both absorption and emission spectra while preserving the compact architecture and synthetic accessibility of the parent coumarin. The resulting dyes combine high molar absorptivity, moderate‐to‐high quantum yields, and exceptional photostability under biologically‐relevant conditions. Their performance was validated in live‐cell imaging using both intensity‐based and fluorescence lifetime imaging microscopy (FLIM), demonstrating compatibility with advanced imaging techniques. Furthermore, site‐specific bioconjugation to a clinically relevant peptide confirmed their suitability for targeted imaging. Collectively, π‐extended COUPY dyes represent a promising class of synthetically modular, chemically robust, and biologically compatible far‐red/NIR fluorophores for high‐resolution imaging, targeted strategies, and advanced bioimaging modalities, and provide a foundation for future studies aimed at evaluating their performance in more complex biological models.
- Open Access
- 23 June 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (34) , e9647759
π‐Extended COUPY Fluorophores for Targeted Near‐Infrared Fluorescence and Lifetime Imaging in Live Cells
Fluorescent probes operating in the near‐infrared (NIR) region offer deep‐tissue visualization with minimal background interference, reduced phototoxicity, and enhanced signal‐to‐noise ratios. However, most conventional NIR fluorophores exhibit poor photostability, low fluorescence quantum yields, and limited chemical versatility, which constrain their use in demanding biological environments. Here, we report a new family of π‐extended COUPY dyes ( 3 – 7 ), rationally engineered to deliver efficient far‐red/NIR performance through vinylogation of the exocyclic double bond of the coumarin scaffold. This single structural modification induces a bathochromic shift exceeding 100 nm in both absorption and emission spectra while preserving the compact architecture and synthetic accessibility of the parent coumarin. The resulting dyes combine high molar absorptivity, moderate‐to‐high quantum yields, and exceptional photostability under biologically‐relevant conditions. Their performance was validated in live‐cell imaging using both intensity‐based and fluorescence lifetime imaging microscopy (FLIM), demonstrating compatibility with advanced imaging techniques. Furthermore, site‐specific bioconjugation to a clinically relevant peptide confirmed their suitability for targeted imaging. Collectively, π‐extended COUPY dyes represent a promising class of synthetically modular, chemically robust, and biologically compatible far‐red/NIR fluorophores for high‐resolution imaging, targeted strategies, and advanced bioimaging modalities, and provide a foundation for future studies aimed at evaluating their performance in more complex biological models.
- 23 June 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (34) , e9647759
Open Accessπ‐Extended COUPY Fluorophores for Targeted Near‐Infrared Fluorescence and Lifetime Imaging in Live Cells
Fluorescent probes operating in the near‐infrared (NIR) region offer deep‐tissue visualization with minimal background interference, reduced phototoxicity, and enhanced signal‐to‐noise ratios. However, most conventional NIR fluorophores exhibit poor photostability, low fluorescence quantum yields, and limited chemical versatility, which constrain their use in demanding biological environments. Here, we report a new family of π‐extended COUPY dyes ( 3 – 7 ), rationally engineered to deliver efficient far‐red/NIR performance through vinylogation of the exocyclic double bond of the coumarin scaffold. This single structural modification induces a bathochromic shift exceeding 100 nm in both absorption and emission spectra while preserving the compact architecture and synthetic accessibility of the parent coumarin. The resulting dyes combine high molar absorptivity, moderate‐to‐high quantum yields, and exceptional photostability under biologically‐relevant conditions. Their performance was validated in live‐cell imaging using both intensity‐based and fluorescence lifetime imaging microscopy (FLIM), demonstrating compatibility with advanced imaging techniques. Furthermore, site‐specific bioconjugation to a clinically relevant peptide confirmed their suitability for targeted imaging. Collectively, π‐extended COUPY dyes represent a promising class of synthetically modular, chemically robust, and biologically compatible far‐red/NIR fluorophores for high‐resolution imaging, targeted strategies, and advanced bioimaging modalities, and provide a foundation for future studies aimed at evaluating their performance in more complex biological models.
- Open Access
- 15 February 2026
- Published by The Company of Biologists in Development
- Vol. 153 (4)
Sex-dependent plasticity of adult neural tissue in response to damage
The plasticity of intact adult neural tissue in the vicinity of neural damage helps restore circuit function. Much remains to be learned about the mechanisms regulating this process and the reported sex differences in recovery outcomes. Here, we present the fly gut and its innervation as a simplified model to address these questions. We show that ingestion of damaging agents triggers a reversible increase in adult enteric neural tissue in females, consistent with growth rather than neurogenesis. This growth can be influenced by gut-derived reactive oxygen species, as suggested by suppression with an antioxidant. Interestingly, males do not display neural plasticity, and masculinization of neurons in females suppresses damage-dependent neural growth. Conversely, feminizing male neurons does not confer plasticity, suggesting that sex-specific cues from surrounding tissues may be required for this response. Blocking plasticity reduces the dextran sulfate sodium-induced increase in defecation and further shortens survival, indicating that female-specific neural plasticity supports both gut function and viability. Together, these findings establish a physiological model to dissect cellular, molecular and sex-dependent regulators of adult neural plasticity relevant to circuit repair.
- 15 February 2026
- Published by The Company of Biologists in Development
- Vol. 153 (4)
Open AccessSex-dependent plasticity of adult neural tissue in response to damage
The plasticity of intact adult neural tissue in the vicinity of neural damage helps restore circuit function. Much remains to be learned about the mechanisms regulating this process and the reported sex differences in recovery outcomes. Here, we present the fly gut and its innervation as a simplified model to address these questions. We show that ingestion of damaging agents triggers a reversible increase in adult enteric neural tissue in females, consistent with growth rather than neurogenesis. This growth can be influenced by gut-derived reactive oxygen species, as suggested by suppression with an antioxidant. Interestingly, males do not display neural plasticity, and masculinization of neurons in females suppresses damage-dependent neural growth. Conversely, feminizing male neurons does not confer plasticity, suggesting that sex-specific cues from surrounding tissues may be required for this response. Blocking plasticity reduces the dextran sulfate sodium-induced increase in defecation and further shortens survival, indicating that female-specific neural plasticity supports both gut function and viability. Together, these findings establish a physiological model to dissect cellular, molecular and sex-dependent regulators of adult neural plasticity relevant to circuit repair.
- Open Access
- 20 December 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (3) , 1585-1601
Novel Heteroleptic Iridium(III) Complexes Containing COUBPY Ligands for Effective Photoinduction of Ferroptosis for Cancer Therapy
Ferroptosis, a recently described form of regulated, nonapoptotic cell death mechanism, presents significant potential for cancer treatment, particularly when combined with photodynamic therapy (PDT). In this study, we report the synthesis and biological evaluation of a series of Ir-COUBPY complexes as novel photosensitizers (PSs) for effective cancer phototherapy. These complexes exhibit high stability under both dark and light conditions and are capable of photogenerating Type I and Type II reactive oxygen species (ROS), as well as photo-oxidizing NADH. Electron paramagnetic resonance (EPR) spectroscopy provided direct evidence of light-induced superoxide and singlet oxygen generation, confirming dual ROS pathways. Moreover, the Ir-COUBPY complexes preferentially accumulated in the mitochondria of cancer cells, leading to the photogeneration of hydroxyl radicals and hydrogen peroxide. Photocytotoxicity studies on HeLa and A375 cancer cells underscored the role of the COUBPY ligand in enhancing PDT efficiency upon irradiation with both green and red light. Among the Ir-COUBPY complexes, the most effective PS, Ir4a, was encapsulated in polyurethane–polyurea hybrid nanocapsules (NC-Ir4a), resulting in a significant increase in phototoxic index values (e.g., from 64 to 179.6 in A375 cells). Mechanistic studies confirmed ferroptosis as the primary cell death pathway induced by Ir4a, supported by light-dependent lipid peroxidation, glutathione oxidation and depletion, intracellular ATP photodepletion, and the viability-restoring effect of Fer-1. These effects were more pronounced upon nanoencapsulation. Photobiological studies with 3D tumor spheroids of A375 cells further confirmed higher cellular uptake of NC-Ir4a, contributing to improved phototoxic efficiency. Overall, these findings highlight the potential of coumarin-based COUBPY ligands in the design of new Ir(III)-based PSs that can be activated with light within the phototherapeutic window, operating through nonconventional cell death mechanisms such as ferroptosis.
- 20 December 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (3) , 1585-1601
Open AccessNovel Heteroleptic Iridium(III) Complexes Containing COUBPY Ligands for Effective Photoinduction of Ferroptosis for Cancer Therapy
Ferroptosis, a recently described form of regulated, nonapoptotic cell death mechanism, presents significant potential for cancer treatment, particularly when combined with photodynamic therapy (PDT). In this study, we report the synthesis and biological evaluation of a series of Ir-COUBPY complexes as novel photosensitizers (PSs) for effective cancer phototherapy. These complexes exhibit high stability under both dark and light conditions and are capable of photogenerating Type I and Type II reactive oxygen species (ROS), as well as photo-oxidizing NADH. Electron paramagnetic resonance (EPR) spectroscopy provided direct evidence of light-induced superoxide and singlet oxygen generation, confirming dual ROS pathways. Moreover, the Ir-COUBPY complexes preferentially accumulated in the mitochondria of cancer cells, leading to the photogeneration of hydroxyl radicals and hydrogen peroxide. Photocytotoxicity studies on HeLa and A375 cancer cells underscored the role of the COUBPY ligand in enhancing PDT efficiency upon irradiation with both green and red light. Among the Ir-COUBPY complexes, the most effective PS, Ir4a, was encapsulated in polyurethane–polyurea hybrid nanocapsules (NC-Ir4a), resulting in a significant increase in phototoxic index values (e.g., from 64 to 179.6 in A375 cells). Mechanistic studies confirmed ferroptosis as the primary cell death pathway induced by Ir4a, supported by light-dependent lipid peroxidation, glutathione oxidation and depletion, intracellular ATP photodepletion, and the viability-restoring effect of Fer-1. These effects were more pronounced upon nanoencapsulation. Photobiological studies with 3D tumor spheroids of A375 cells further confirmed higher cellular uptake of NC-Ir4a, contributing to improved phototoxic efficiency. Overall, these findings highlight the potential of coumarin-based COUBPY ligands in the design of new Ir(III)-based PSs that can be activated with light within the phototherapeutic window, operating through nonconventional cell death mechanisms such as ferroptosis.
- Open Access
- 8 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (50) , 46291-46304
π-Extended Ru–COUBPY Photosensitizers for In Vivo Anticancer Phototherapy Using One-Photon 780 nm Near-Infrared Light
Photodynamic therapy (PDT) is a promising cancer treatment modality, offering precise spatial and temporal control of drug activation using light. However, clinical translation of current photosensitizers (PSs) is limited by inefficient activation at wavelengths within the phototherapeutic window, especially in the deep-red and near-infrared (NIR) region. NIR light provides advantages such as reduced absorption by endogenous chromophores, minimized tissue photodamage, and improved tissue penetration, highlighting the need for PSs to be activatable in this range. Herein, we report a novel series of ruthenium(II) polypyridyl complexes (Ru4-7) featuring π-extended COUBPY ligands, designed via a vinylogation strategy and synthesized through an innovative postcoordination ligand assembly approach. This structural modification enhances molar absorptivity and red-shifts the absorption bands well into the NIR region without substantially compromising photostability. Complexes Ru4-7 efficiently generate both Type I and Type II reactive oxygen species, and their photodynamic activity, combined with preferential mitochondrial accumulation, leads to potent nanomolar phototoxicity against CT-26 colorectal cancer cells under deep-red and NIR irradiation, even under hypoxia. Notably, the lead complex Ru6 demonstrated strong in vivo phototoxicity in mice bearing subcutaneous CT-26 tumors, achieving significant tumor growth inhibition upon irradiation with 660 and 780 nm light. Ru6 thus represents one of the first Ru(II) polypyridyl complexes to exhibit robust in vivo PDT antitumor activity under one-photon NIR activation. Its broad wavelength activation profile further underscores its potential versatility for treating tumors of varying size and anatomical location depending on specific light penetration requirements. These findings mark a promising step toward next-generation PSs for treating deep-seated and hypoxic tumors.
- 8 December 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (50) , 46291-46304
Open Accessπ-Extended Ru–COUBPY Photosensitizers for In Vivo Anticancer Phototherapy Using One-Photon 780 nm Near-Infrared Light
Photodynamic therapy (PDT) is a promising cancer treatment modality, offering precise spatial and temporal control of drug activation using light. However, clinical translation of current photosensitizers (PSs) is limited by inefficient activation at wavelengths within the phototherapeutic window, especially in the deep-red and near-infrared (NIR) region. NIR light provides advantages such as reduced absorption by endogenous chromophores, minimized tissue photodamage, and improved tissue penetration, highlighting the need for PSs to be activatable in this range. Herein, we report a novel series of ruthenium(II) polypyridyl complexes (Ru4-7) featuring π-extended COUBPY ligands, designed via a vinylogation strategy and synthesized through an innovative postcoordination ligand assembly approach. This structural modification enhances molar absorptivity and red-shifts the absorption bands well into the NIR region without substantially compromising photostability. Complexes Ru4-7 efficiently generate both Type I and Type II reactive oxygen species, and their photodynamic activity, combined with preferential mitochondrial accumulation, leads to potent nanomolar phototoxicity against CT-26 colorectal cancer cells under deep-red and NIR irradiation, even under hypoxia. Notably, the lead complex Ru6 demonstrated strong in vivo phototoxicity in mice bearing subcutaneous CT-26 tumors, achieving significant tumor growth inhibition upon irradiation with 660 and 780 nm light. Ru6 thus represents one of the first Ru(II) polypyridyl complexes to exhibit robust in vivo PDT antitumor activity under one-photon NIR activation. Its broad wavelength activation profile further underscores its potential versatility for treating tumors of varying size and anatomical location depending on specific light penetration requirements. These findings mark a promising step toward next-generation PSs for treating deep-seated and hypoxic tumors.
- Open Access
Sex-dependent plasticity of adult neural tissue in response to damage
Plasticity of intact adult neural tissue in the vicinity of neural damage serves to restore functionality of circuits. Much remains to be learned about the mechanisms regulating this process and the reported sex differences in recovery outcomes. Here, we present the fly gut and its innervation as a simplified model to address these questions. We show that gut damage caused by ingestion of toxic agents resulted in plasticity of the adult enteric neuronal network, manifested as a Reactive Oxygen Species (ROS)-dependent increase in neural tissue, which was reversible after a recovery period. Interestingly, males did not display neural plasticity, and masculinization of neurons in females suppressed the damage-dependent neural growth. Together, these findings position the fly gut as a system to investigate the cellular, molecular, and sex-specific underpinnings of neural plasticity, with implications for therapeutic advancements in neural circuit recovery. SUMMARY STATEMENT: This study establishes the fly gut as a simple system to explore how adult neural tissues differ between sexes in their capacity for plasticity.
Open AccessSex-dependent plasticity of adult neural tissue in response to damage
Plasticity of intact adult neural tissue in the vicinity of neural damage serves to restore functionality of circuits. Much remains to be learned about the mechanisms regulating this process and the reported sex differences in recovery outcomes. Here, we present the fly gut and its innervation as a simplified model to address these questions. We show that gut damage caused by ingestion of toxic agents resulted in plasticity of the adult enteric neuronal network, manifested as a Reactive Oxygen Species (ROS)-dependent increase in neural tissue, which was reversible after a recovery period. Interestingly, males did not display neural plasticity, and masculinization of neurons in females suppressed the damage-dependent neural growth. Together, these findings position the fly gut as a system to investigate the cellular, molecular, and sex-specific underpinnings of neural plasticity, with implications for therapeutic advancements in neural circuit recovery. SUMMARY STATEMENT: This study establishes the fly gut as a simple system to explore how adult neural tissues differ between sexes in their capacity for plasticity.
- Open Access
- 28 April 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (9) , 9741-9754
Exploring the Phototherapeutic Applications of Mitochondria-Targeted COUPY Photocages of Antitumor Drugs
Photocleavable protecting groups hold great promise in photopharmacology to control the release of bioactive molecules from their caged precursors within specific subcellular compartments. Herein, we describe a series of photocages based on a COUPY scaffold, incorporating chlorambucil (CLB) and 4-phenylbutyric acid (4-PBA) as bioactive payloads that can be efficiently activated with visible light. Confocal microscopy confirmed the preferential accumulation of CLB and 4-PBA N-hexyl COUPY photocages in the mitochondria, which exhibited a remarkable phototoxicity against cancer cells upon green-yellow light irradiation, with IC50 values in the nanomolar range. This effect was attributed to a synergistic mechanism involving the photorelease of the bioactive payloads and the intrinsic photogeneration of Type I and Type II ROS by the COUPY scaffold within mitochondria. Thus, COUPY-caged derivatives of CLB and 4-PBA underscore the potential of COUPY-caging groups as a versatile platform to develop innovative light-activated agents operating simultaneously through photodynamic therapy and photoactivated chemotherapy.
- 28 April 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (9) , 9741-9754
Open AccessExploring the Phototherapeutic Applications of Mitochondria-Targeted COUPY Photocages of Antitumor Drugs
Photocleavable protecting groups hold great promise in photopharmacology to control the release of bioactive molecules from their caged precursors within specific subcellular compartments. Herein, we describe a series of photocages based on a COUPY scaffold, incorporating chlorambucil (CLB) and 4-phenylbutyric acid (4-PBA) as bioactive payloads that can be efficiently activated with visible light. Confocal microscopy confirmed the preferential accumulation of CLB and 4-PBA N-hexyl COUPY photocages in the mitochondria, which exhibited a remarkable phototoxicity against cancer cells upon green-yellow light irradiation, with IC50 values in the nanomolar range. This effect was attributed to a synergistic mechanism involving the photorelease of the bioactive payloads and the intrinsic photogeneration of Type I and Type II ROS by the COUPY scaffold within mitochondria. Thus, COUPY-caged derivatives of CLB and 4-PBA underscore the potential of COUPY-caging groups as a versatile platform to develop innovative light-activated agents operating simultaneously through photodynamic therapy and photoactivated chemotherapy.
- Top Cited PapersOpen Access
- 15 February 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (9) , 7360-7376
Ruthenium(II) Polypyridyl Complexes Containing COUBPY Ligands as Potent Photosensitizers for the Efficient Phototherapy of Hypoxic Tumors
Hypoxia, a hallmark of many solid tumors, is linked to increased cancer aggressiveness, metastasis, and resistance to conventional therapies, leading to poor patient outcomes. This challenges the efficiency of photodynamic therapy (PDT), which relies on the generation of cytotoxic reactive oxygen species (ROS) through the irradiation of a photosensitizer (PS), a process partially dependent on oxygen levels. In this work, we introduce a novel family of potent PSs based on ruthenium(II) polypyridyl complexes with 2,2'-bipyridyl ligands derived from COUPY coumarins, termed COUBPYs. Ru-COUBPY complexes exhibit outstanding in vitro cytotoxicity against CT-26 cancer cells when irradiated with light within the phototherapeutic window, achieving nanomolar potency in both normoxic and hypoxic conditions while remaining nontoxic in the dark, leading to impressive phototoxic indices (>30,000). Their ability to generate both Type I and Type II ROS underpins their exceptional PDT efficiency. The lead compound of this study, SCV49, shows a favorable in vivo pharmacokinetic profile, excellent toxicological tolerability, and potent tumor growth inhibition in mice bearing subcutaneous CT-26 tumors at doses as low as 3 mg/kg upon irradiation with deep-red light (660 nm). These results allow us to propose SCV49 as a strong candidate for further preclinical development, particularly for treating large hypoxic solid tumors.
- 15 February 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (9) , 7360-7376
Top Cited PapersOpen AccessRuthenium(II) Polypyridyl Complexes Containing COUBPY Ligands as Potent Photosensitizers for the Efficient Phototherapy of Hypoxic Tumors
Hypoxia, a hallmark of many solid tumors, is linked to increased cancer aggressiveness, metastasis, and resistance to conventional therapies, leading to poor patient outcomes. This challenges the efficiency of photodynamic therapy (PDT), which relies on the generation of cytotoxic reactive oxygen species (ROS) through the irradiation of a photosensitizer (PS), a process partially dependent on oxygen levels. In this work, we introduce a novel family of potent PSs based on ruthenium(II) polypyridyl complexes with 2,2'-bipyridyl ligands derived from COUPY coumarins, termed COUBPYs. Ru-COUBPY complexes exhibit outstanding in vitro cytotoxicity against CT-26 cancer cells when irradiated with light within the phototherapeutic window, achieving nanomolar potency in both normoxic and hypoxic conditions while remaining nontoxic in the dark, leading to impressive phototoxic indices (>30,000). Their ability to generate both Type I and Type II ROS underpins their exceptional PDT efficiency. The lead compound of this study, SCV49, shows a favorable in vivo pharmacokinetic profile, excellent toxicological tolerability, and potent tumor growth inhibition in mice bearing subcutaneous CT-26 tumors at doses as low as 3 mg/kg upon irradiation with deep-red light (660 nm). These results allow us to propose SCV49 as a strong candidate for further preclinical development, particularly for treating large hypoxic solid tumors.
- Open Access
- 23 July 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (30) , 38916-38930
A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent
Despite the potential of photodynamic therapy (PDT) in cancer treatment, the development of efficient and photostable photosensitizing molecules that operate at long wavelengths of light has become a major hurdle. Here, we report for the first time an Ir(III)-phthalocyanine conjugate (Ir-ZnPc) as a novel photosensitizer for high-efficiency synergistic PDT treatment that takes advantage of the long-wavelength excitation and near infrared (NIR) emission of the phthalocyanine scaffold and the known photostability and high phototoxicity of cyclometalated Ir(III) complexes. In order to increase water solubility and cell membrane permeability, the conjugate and parent zinc phthalocyanine (ZnPc) were encapsulated in amphoteric redox-responsive polyurethane-polyurea hybrid nanocapsules (Ir-ZnPc-NCs and ZnPc-NCs, respectively). Photobiological evaluations revealed that the encapsulated Ir-ZnPc conjugate achieved high photocytotoxicity in both normoxic and hypoxic conditions under 630 nm light irradiation, which can be attributed to dual Type I and Type II reactive oxygen species (ROS) photogeneration. Interestingly, PDT treatments with Ir-ZnPc-NCs and ZnPc-NCs significantly inhibited the growth of three-dimensional (3D) multicellular tumor spheroids. Overall, the nanoencapsulation of Zn phthalocyanines conjugated to cyclometalated Ir(III) complexes provides a new strategy for obtaining photostable and biocompatible red-light-activated nano-PDT agents with efficient performance under challenging hypoxic environments, thus offering new therapeutic opportunities for cancer treatment.
- 23 July 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (30) , 38916-38930
Open AccessA Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent
Despite the potential of photodynamic therapy (PDT) in cancer treatment, the development of efficient and photostable photosensitizing molecules that operate at long wavelengths of light has become a major hurdle. Here, we report for the first time an Ir(III)-phthalocyanine conjugate (Ir-ZnPc) as a novel photosensitizer for high-efficiency synergistic PDT treatment that takes advantage of the long-wavelength excitation and near infrared (NIR) emission of the phthalocyanine scaffold and the known photostability and high phototoxicity of cyclometalated Ir(III) complexes. In order to increase water solubility and cell membrane permeability, the conjugate and parent zinc phthalocyanine (ZnPc) were encapsulated in amphoteric redox-responsive polyurethane-polyurea hybrid nanocapsules (Ir-ZnPc-NCs and ZnPc-NCs, respectively). Photobiological evaluations revealed that the encapsulated Ir-ZnPc conjugate achieved high photocytotoxicity in both normoxic and hypoxic conditions under 630 nm light irradiation, which can be attributed to dual Type I and Type II reactive oxygen species (ROS) photogeneration. Interestingly, PDT treatments with Ir-ZnPc-NCs and ZnPc-NCs significantly inhibited the growth of three-dimensional (3D) multicellular tumor spheroids. Overall, the nanoencapsulation of Zn phthalocyanines conjugated to cyclometalated Ir(III) complexes provides a new strategy for obtaining photostable and biocompatible red-light-activated nano-PDT agents with efficient performance under challenging hypoxic environments, thus offering new therapeutic opportunities for cancer treatment.
- Open Access
- 14 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5338
Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 in the Interleukin-1β-Induced Inflammation Model of Intestinal Epithelial Cells
Inflammatory bowel disease (IBD) is a chronic inflammatory condition involving dysregulated immune responses and imbalances in the gut microbiota in genetically susceptible individuals. Current therapies for IBD often have significant side-effects and limited success, prompting the search for novel therapeutic strategies. Microbiome-based approaches aim to restore the gut microbiota balance towards anti-inflammatory and mucosa-healing profiles. Extracellular vesicles (EVs) from beneficial gut microbes are emerging as potential postbiotics. Serotonin plays a crucial role in intestinal homeostasis, and its dysregulation is associated with IBD severity. Our study investigated the impact of EVs from the probiotic Nissle 1917 (EcN) and commensal E. coli on intestinal serotonin metabolism under inflammatory conditions using an IL-1β-induced inflammation model in Caco-2 cells. We found strain-specific effects. Specifically, EcN EVs reduced free serotonin levels by upregulating SERT expression through the downregulation of miR-24, miR-200a, TLR4, and NOD1. Additionally, EcN EVs mitigated IL-1β-induced changes in tight junction proteins and oxidative stress markers. These findings underscore the potential of postbiotic interventions as a therapeutic approach for IBD and related pathologies, with EcN EVs exhibiting promise in modulating serotonin metabolism and preserving intestinal barrier integrity. This study is the first to demonstrate the regulation of miR-24 and miR-200a by probiotic-derived EVs.
- 14 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5338
Open AccessModulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 in the Interleukin-1β-Induced Inflammation Model of Intestinal Epithelial Cells
Inflammatory bowel disease (IBD) is a chronic inflammatory condition involving dysregulated immune responses and imbalances in the gut microbiota in genetically susceptible individuals. Current therapies for IBD often have significant side-effects and limited success, prompting the search for novel therapeutic strategies. Microbiome-based approaches aim to restore the gut microbiota balance towards anti-inflammatory and mucosa-healing profiles. Extracellular vesicles (EVs) from beneficial gut microbes are emerging as potential postbiotics. Serotonin plays a crucial role in intestinal homeostasis, and its dysregulation is associated with IBD severity. Our study investigated the impact of EVs from the probiotic Nissle 1917 (EcN) and commensal E. coli on intestinal serotonin metabolism under inflammatory conditions using an IL-1β-induced inflammation model in Caco-2 cells. We found strain-specific effects. Specifically, EcN EVs reduced free serotonin levels by upregulating SERT expression through the downregulation of miR-24, miR-200a, TLR4, and NOD1. Additionally, EcN EVs mitigated IL-1β-induced changes in tight junction proteins and oxidative stress markers. These findings underscore the potential of postbiotic interventions as a therapeutic approach for IBD and related pathologies, with EcN EVs exhibiting promise in modulating serotonin metabolism and preserving intestinal barrier integrity. This study is the first to demonstrate the regulation of miR-24 and miR-200a by probiotic-derived EVs.